BSE Live
Oct 07, 16:01Prev. Close
15157.30
Open Price
15164.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 07, 15:55Prev. Close
15163.00
Open Price
15162.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
15831.00 (130)
Key Financial Ratios of Neuland Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 202.20 | 233.51 | 127.14 | 49.52 | 62.58 | |
Diluted EPS (Rs.) | 202.20 | 233.51 | 127.14 | 49.52 | 62.58 | |
Cash EPS (Rs.) | 251.90 | 278.51 | 167.35 | 87.26 | 93.00 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 1,175.89 | 988.88 | 765.49 | 647.06 | 605.44 | |
Book Value [InclRevalReserve]/Share (Rs.) | 1,176.54 | 989.53 | 766.14 | 647.71 | 606.09 | |
Dividend / Share(Rs.) | 12.00 | 14.00 | 10.00 | 5.00 | 5.00 | |
Revenue from Operations/Share (Rs.) | 1,144.79 | 1,208.16 | 923.37 | 737.24 | 726.26 | |
PBDIT/Share (Rs.) | 265.73 | 367.79 | 217.86 | 111.83 | 125.99 | |
PBIT/Share (Rs.) | 214.93 | 321.51 | 176.95 | 73.82 | 95.24 | |
PBT/Share (Rs.) | 267.72 | 310.66 | 166.83 | 63.36 | 81.36 | |
Net Profit/Share (Rs.) | 201.10 | 232.24 | 126.44 | 49.25 | 62.24 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 23.21 | 30.44 | 23.59 | 15.16 | 17.34 | |
PBIT Margin (%) | 18.77 | 26.61 | 19.16 | 10.01 | 13.11 | |
PBT Margin (%) | 23.38 | 25.71 | 18.06 | 8.59 | 11.20 | |
Net Profit Margin (%) | 17.56 | 19.22 | 13.69 | 6.68 | 8.57 | |
Return on Networth / Equity (%) | 17.10 | 23.48 | 16.51 | 7.61 | 10.28 | |
Return on Capital Employed (%) | 16.25 | 29.68 | 20.13 | 9.39 | 12.92 | |
Return on Assets (%) | 11.91 | 16.36 | 10.32 | 4.59 | 6.06 | |
Total Debt/Equity (X) | 0.09 | 0.06 | 0.12 | 0.28 | 0.19 | |
Asset Turnover Ratio (%) | 0.74 | 0.91 | 0.80 | 0.70 | 70.78 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 2.41 | 2.12 | 1.71 | 1.58 | 1.47 | |
Quick Ratio (X) | 1.59 | 1.31 | 1.08 | 0.86 | 0.81 | |
Inventory Turnover Ratio (X) | 3.90 | 2.01 | 1.79 | 1.71 | 3.78 | |
Dividend Payout Ratio (NP) (%) | 6.92 | 4.28 | 3.93 | 6.05 | 3.19 | |
Dividend Payout Ratio (CP) (%) | 5.52 | 3.57 | 2.97 | 3.41 | 2.13 | |
Earnings Retention Ratio (%) | 93.08 | 95.72 | 96.07 | 93.95 | 96.81 | |
Cash Earnings Retention Ratio (%) | 94.48 | 96.43 | 97.03 | 96.59 | 97.87 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 15,458.61 | 8,070.41 | 2,384.24 | 1,536.32 | 2,820.60 | |
EV/Net Operating Revenue (X) | 10.47 | 5.18 | 2.00 | 1.62 | 3.01 | |
EV/EBITDA (X) | 45.09 | 17.01 | 8.48 | 10.65 | 17.35 | |
MarketCap/Net Operating Revenue (X) | 10.55 | 5.20 | 1.95 | 1.39 | 2.87 | |
Retention Ratios (%) | 93.07 | 95.71 | 96.06 | 93.94 | 96.80 | |
Price/BV (X) | 10.27 | 6.35 | 2.35 | 1.59 | 3.45 | |
Price/Net Operating Revenue | 10.55 | 5.20 | 1.95 | 1.39 | 2.87 | |
Earnings Yield | 0.02 | 0.04 | 0.07 | 0.05 | 0.03 |
15.09.2025
01.08.2025
Neuland Lab Consolidated June 2025 Net Sales at Rs 292.75 crore, down 33.41% Y-o-Y
01.08.2025
Neuland Lab Standalone June 2025 Net Sales at Rs 292.75 crore, down 33.41% Y-o-Y
01.08.2025
01.08.2025
Neuland Lab Consolidated June 2025 Net Sales at Rs 292.75 crore, down 33.41% Y-o-Y
01.08.2025
Neuland Lab Standalone June 2025 Net Sales at Rs 292.75 crore, down 33.41% Y-o-Y
16.05.2025
Neuland Lab Consolidated March 2025 Net Sales at Rs 328.36 crore, down 14.71% Y-o-Y
15.05.2025
Neuland Lab Standalone March 2025 Net Sales at Rs 328.36 crore, down 14.71% Y-o-Y